167 related articles for article (PubMed ID: 2990874)
21. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
[TBL] [Abstract][Full Text] [Related]
22. Carbachol-induced decrease in thyroid cell adenylyl cyclase activity is independent of calcium and phosphodiesterase activation.
Pasquali D; Rani CS; Deery WJ
Mol Pharmacol; 1992 Jan; 41(1):163-7. PubMed ID: 1310140
[TBL] [Abstract][Full Text] [Related]
23. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
[TBL] [Abstract][Full Text] [Related]
24. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
25. Effects of thyrotropin and cholera toxin on the thyroidal adenylate cyclase-adenosine 3',5'-monophosphate system.
Holmes SD; Titus G; Chou M; Field JB
Endocrinology; 1980 Dec; 107(6):2076-81. PubMed ID: 6253290
[TBL] [Abstract][Full Text] [Related]
26. Amiodarone effects on thyrotropin receptors and responses stimulated by thyrotropin and carbachol in cultured dog thyroid cells.
Rani CS
Endocrinology; 1990 Dec; 127(6):2930-7. PubMed ID: 2174339
[TBL] [Abstract][Full Text] [Related]
27. Thyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasms.
Clark OH; Gerend PL
J Clin Endocrinol Metab; 1985 Oct; 61(4):773-8. PubMed ID: 2993348
[TBL] [Abstract][Full Text] [Related]
28. The biological activity of bovine and human thyrotropin is differently affected by trypsin treatment of human thyroid cells: thyroid-stimulating antibody is related to human thyrotropin.
Foti D; Russo D; Costante G; Filetti S
J Clin Endocrinol Metab; 1991 Oct; 73(4):710-6. PubMed ID: 1679761
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
30. Purification and properties of an Indian major carp (Cirrhinus mrigala, Ham.) pituitary thyrotropin.
Bandyopadhyay S; Bhattacharya S
Gen Comp Endocrinol; 1993 May; 90(2):192-204. PubMed ID: 8319876
[TBL] [Abstract][Full Text] [Related]
31. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
[TBL] [Abstract][Full Text] [Related]
32. Adenosine 3',5'-monophosphate mediates both the mitogenic effect of thyrotropin and its ability to amplify the response to insulin-like growth factor I in FRTL5 cells.
Tramontano D; Moses AC; Veneziani BM; Ingbar SH
Endocrinology; 1988 Jan; 122(1):127-32. PubMed ID: 2446854
[TBL] [Abstract][Full Text] [Related]
33. Graves' immunoglobulins protect the human TSH receptor: further evidence for TSH receptor antibodies in Graves' disease.
Davies TF; Platzer M
Clin Endocrinol (Oxf); 1983 Oct; 19(4):427-35. PubMed ID: 6313261
[TBL] [Abstract][Full Text] [Related]
34. Thyrotropin binding to cultured lymphocytes and thyroid cells.
Pekonen F; Weintraub BD
Endocrinology; 1978 Nov; 103(5):1668-77. PubMed ID: 34508
[TBL] [Abstract][Full Text] [Related]
35. Receptor-binding activity of highly purified bovine luteinizing hormone and thyrotropin, and their subunits.
Williams JF; Davies TF; Catt KJ; Pierce JG
Endocrinology; 1980 May; 106(5):1353-9. PubMed ID: 6244924
[TBL] [Abstract][Full Text] [Related]
36. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms.
Saltiel AR; Powel-Jones CH; Thomas CG; Nayfeh SN
Cancer Res; 1981 Jun; 41(6):2360-5. PubMed ID: 6263464
[TBL] [Abstract][Full Text] [Related]
37. Thyroglobulin inhibition of thyrotropin binding to thyroid plasma membrane.
Hashizume K; Fenzi G; DeGroot LJ
J Clin Endocrinol Metab; 1978 Apr; 46(4):679-85. PubMed ID: 225342
[TBL] [Abstract][Full Text] [Related]
38. Diminished binding of thyroid-stimulating hormone in a transplantable rat thyroid tumor as a possible cause of hormone unresponsiveness.
Mandato E; Meldolesi MF; Macchia V
Cancer Res; 1975 Nov; 35(11 Pt 1):3089-93. PubMed ID: 171062
[TBL] [Abstract][Full Text] [Related]
39. Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes.
Yamashita K; Field JB
J Clin Invest; 1972 Mar; 51(3):463-72. PubMed ID: 4110896
[TBL] [Abstract][Full Text] [Related]
40. On the mechanism of inhibition by iodine of the thyroid adenylate cyclase response to thyrotropic hormone.
Rapoport B; West MN; Ingbar SH
Endocrinology; 1976 Jul; 99(1):11-22. PubMed ID: 181236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
